Propionyl-l-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study

Journal of the American College of Cardiology

Volumn 26, Issue 6, 1995, Pages 1411-1416

  Brevetti, Gregorio ^a   Perna, Sergio ^a   Sabbá, Carlo ^a,b   Martone, Vincenzo Domenico ^a   Condorelli, Mario ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROPIONYLCARNITINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ENERGY METABOLISM; EPIGASTRIC PAIN; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; CARDIOTONIC AGENTS; CARNITINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0028849885     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00344-4     Document Type: Article

References (36)

1. Fate of the patient with chronic leg ischaemia
2. Basic data related to the natural history of intermittent claudication
3. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment
4. Does pentoxifylline have a place in the treatment of intermittent claudication?
5. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical haemostatic and rheologic effects
6. Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965–1985
7. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease
8. Effect of ketanserin in treatment of patients with intermittent claudication: results from 13 placebo-controlled parallel group studies
9. Randomized placebo-controlled, double-blind trial of ketanserin in claudicants
10. Physical training of patients with intermittent claudication: indications, methods and results
11. Effect of physical training on different categories of patients with intermittent claudication
12. Benefit of exercise conditioning for patients with peripheral arterial disease
13. Carnitine metabolism and function
14. Carnitine deficiency of skeletal muscle: report of a treated case
15. Possible causes and effects of carnitine deficiency in man
16. Muscle carnitine deficiency in patients with severe peripheral vascular disease
17. Skeletal muscle camitine metabolism in patients with unilateral peripheral arterial disease
18. Increases in walking distance in patients with peripheral vascular disease treated with l-carnitine: a double-blind, cross-over study
19. Propionyl-l-carnitine: biochemical significance and possible role in cardiac metabolism
20. Superiority of l-propionyl carnitine vs l-carnitine in improving walking capacity in patients with peripheral vascular disease
21. A question of control
22. The analysis of a titration study
23. The analysis of titration studies in phase III clinical trials
24. Another look at the pentoxifylline efficacy data for intermittent claudication
25. Conservative management of intermittent claudication
26. Progressive vs single-stage treadmill tests for evaluation of claudication
27. Double blind study of pentoxifylline against placebo in patients with intermittent claudication
28. Intermittent claudication: a double-blind, crossover study of pentoxifylline
29. Acenocoumarol and pentoxifylline in intermittent claudication
30. The determination of practically useful doses of new drugs: some methodological considerations
31. Pyruvate-dehydrogenase complex: meticulous regulator of glucose disposal in animals
32. Regulation of pyruvate metabolism in mammalian tissue
33. Possible functions of short-chain and medium-chain carnitine acyltransferase
34. Pyruvate carboxylase and propionyl-CoA carboxylase as anaplerotic enzymes in skeletal muscle mitochondria
35. Anaplerotic effect of propionyl carnitine in rat heart mitochondria
36. Effect of propionyl-l-carnitine in a rat model of peripheral arteriopathy: a functional, histologic, and NMR spectroscopic study